Press Release

As China increases tariffs on 128 U.S. products and the first sparks of a trade war begin to fly, President Trump demonstrates a failure to learn lessons from history in his pursuit to make tariffs great again.

In a victory for the Texas economy and consumers, a U.S. District Court judge has ruled against an anti-competitive state law barring publicly traded companies from owning package liquor stores.

 For its next Hatton W. Sumners Distinguished Lecture Series event, IPI will host acclaimed civil liberties attorney Alan M. Dershowitz in Irving on Wednesday, March 28, 2018. The world-renowned litigator will share his concerns on the current state of political discourse.

President Trump has made a wise selection by appointing CNBC contributor, TV and radio host Larry Kudlow, whose creed is “free market capitalism is the best path to prosperity,” to be his chief economic advisor as head of the National Economic Council.

The Institute for Policy Innovation (IPI) is honored to host acclaimed civil liberties attorney Alan M. Dershowitz in Irving on Wednesday, March 28, 2018, as the next of its Hatton W. Sumners Distinguished Lecture Series.

"Twenty states have sued the Trump administration asserting that the tax reform law, which eliminates the Affordable Care Act's mandate to have health insurance, makes Obamacare unconstitutional," said Merrill Matthews. "It's a brilliant argument. 

The Department of Labor’s proposed rulemaking released today would help clear the way for employers to band together in associations and self-insure, and is a good first step in the ongoing but challenging effort to provide employers and employees more flexibility under Obamacare.

IPI enthusiastically commends Congress for finally passing a pro-growth tax reform that represents a much needed reduction in taxes on investment capital and will make the U.S. economy much more globally competitive.

IPI commends the FCC for voting today to overturn the Obama administration’s ill-conceived 2015 reclassification of broadband networks as telephone service until Title II.

In a new publication, “Budgets First, Patients Last: MedPAC's Plan to Undermine Medicare Part B's Drug Benefit,” Matthews says MedPAC’s proposed changes to Medicare Part B’s prescription drug reimbursement plan would put patients' lives at risk by reducing access to care, especially for the sickest and most vulnerable patients — a substantial segment of Medicare’s Part B drug program.